Abbott Laboratories (ABT)
$85.76 2.60 (3.13%)
16:42 EDT ABT Stock Quote Delayed 15 Minutes
Previous Close $83.16
Market Cap 150.35B
PE Ratio 408.38
Volume (Avg. Vol.) 9.36M
Day's Range 85.43 - 86.75
52-Week Range 61.56 - 85.99
Dividend & Yield 1.12 (1.31%)
ABT Stock Predictions, Articles, and Abbott Laboratories News
- From InvestorPlace
- From the Web
Tesla, Teva, Abbott Labs, Invitae and the gold ETF were are top stock trades on Wednesday. Let's look at the setups heading into Thursday.
Abbott Laboratories earnings for the company's second quarter of 2019 has ABT stock heading higher Wednesday on positive results.
These healthcare stocks are breaking down on the charts. Investors should be careful before stepping into these four.
Abbott Laboratories earnings for the first quarter of 2019 have ABT stock down on Wednesday despite it beating estimates.
Abbott Labs (ABT) stock was down more than 2% on Wednesday despite the fact that the company's fourth-quarter earnings reached expectations.
IBM, Abbott Labs, Papa John's, Starbucks and Disney round out our must-see stock charts for Thursday. Here's why.
Abbott is about to report another quarter to cap 2018's strong annual performance. ABT stock also offers a dividend for income investors.
These consumer stocks offer generous, growing dividends and should return to a growth trajectory based on new business lines.
The stock charts of INCY, ABT and SLB are set to end the week on a more definitive, trade-worthy footing than most other names.
A buyout for Ceasars? Earnings from Netflix, Abbott and Lam Research -- we've got it all covered in our top stock trades article.
The short-term nature of the stock markets makes it hard for companies to think bigger picture -- but these seven best long-term stocks do.
There are dividend stocks, and then there are dividend aristocrats. These ten names are the income producers you rarely have to worry about.
We take a closer look at 10 stocks RBC Capital has pinpointed as the leaders and laggards of the future. These are the stocks that are set to outperform in 2025, but also the stocks facing the biggest risks from our ever-changing society.
Abbott Laboratories (ABT) stock was up on Wednesday following the release of its earnings report for the second quarter of 2018.
Stock charts of United Technologies, Abbott Laboratories and Leggett & Platt have earned a closer look as bullish trading prospects this morning.
Abbott Laboratories (ABT) stock as down on Wednesday despite the health care company reporting an earnings beat for the first quarter of 2018.
The Buy for Abbott Laboratories (ABT) this week is based on the latest relative pricing of its shares and market intelligence.
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!